Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J E Bradner
HEXIM1 Induction Is Mechanistically Involved in Mediating Anti-Aml Activity of BET Protein Bromodomain Antagonist
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Identification of Bromodomain-Containing Protein-4 as a Novel Marker and Epigenetic Target in Mast Cell Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
BET Protein Bromodomain Inhibitor-Based Combinations Are Highly Active Against Post-Myeloproliferative Neoplasm Secondary AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Fatty Acid-Binding Protein FABP4 Mechanistically Links Obesity With Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Induction of the WNT Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage
PLoS ONE
Multidisciplinary
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
Synergistic Induction of Cell Death in Haematological Malignancies by Combined Phosphoinositide-3-Kinase and BET Bromodomain Inhibition
British Journal of Haematology
Hematology
PROTAC Induced-Bet Protein Degradation Exhibits Potent Anti-Osteosarcoma Activity by Triggering Apoptosis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Bromodomain and Extraterminal (BET) Proteins Regulate Biliary-Driven Liver Regeneration
Journal of Hepatology
Hepatology
Daunorubicin Dose in AML Induction
Blood
Biochemistry
Immunology
Cell Biology
Hematology